Cuba successfully developed a lung cancer vaccine

Cuba Molecular Immunology Center (CIM) announced on December 31 that it has successfully prepared a new vaccine to prevent lung cancer.

>>>Cuba tested prostate cancer vaccine

According to CIM researcher Ana Maria Vazquez (Ana Maria Vazquez), the vaccine, called Racotumomab , has been clinically tested throughout the year and demonstrates the ability of cancer patients to increase survival rates, as well. as shown by the safety and tolerance of drugs.

This new vaccine helps fight lung carcinoma by promoting the destruction of cancer cells and limiting the appearance of tumors.

Racotumomab is the second vaccine line developed by CIM to prevent lung cancer, after the CIMAvax EGF series has been proven effective in treating cancer patients in Cuba.

Lung cancer is the second most common cancer in Cuba with about 5,000 cases in the pre-existing stage of the disease.